Brought to you by:
Deep vein arterialization challenges notion of ‘no-option’ CLTI
“Patients previously considered ‘no-option’ may no longer truly be without options,” said Anahita Dua, MD, associate professor at Harvard Medical School and a vascular surgeon at Massachusetts General Hospital. That assertion sums up the central finding of an analysis comparing…
DCB therapy reduces MALE rates across femoropopliteal lesion complexity
In an era of expanding device options and the clinical temptation to match procedural complexity to lesion complexity, a new study offers a counterintuitive but data-driven argument: In femoropopliteal disease, doing less may actually deliver more. Research using the Vascular…
Pre-operative guideline adherence tied to fewer major adverse limb events
For patients with claudication, surgical revascularization is meant to restore quality of life. But a new retrospective study finds that most patients are arriving for that intervention without completing the pre-operative care that guidelines recommend and that the shortfall carries…
Tibial access in claudicants linked to guideline-discordant care and CLTI progression
Retrograde tibial access has long offered technical advantages in peripheral vascular procedures, but a new study raises concern that its use in patients with claudication may be driving treatment decisions that exceed what current guidelines recommend, creating a clinically significant…
Data shows disease severity drives ALI outcomes more than treatment choice
A large retrospective study of patients with acute limb ischemia (ALI) found that early outcomes including limb salvage, survival and amputation-free survival are equivalent between open surgery-first and endovascular-first revascularization strategies. The research determined that outcomes were driven primarily by…
Advancing the SVS mission to provide patients with expert vascular care
During the upcoming year, I plan to provide a monthly summary of critical issues the SVS is facing to keep you better informed. There are more than 100 projects SVS committees, councils and task forces are working on, so I…
SVS International Committee’s 2025 scholars named
The SVS International Relations Committee (IRC) has announced the recipients of the 2025 International Scholars Program, recognizing the achievements of three distinguished professionals: Sohei Matsuura, MD, from Japan; Rahel Abebayehu Assefa, MD, from Ethiopia; and Prajna Kota, MD, from India.…
Search for new JVS editor-in-chief has commenced
The Society for Vascular Surgery (SVS) has launched a search for a new editor-in-chief (EIC) for its flagship publication, the Journal of Vascular Surgery (JVS). The selected EIC will oversee the academic and editorial quality of JVS and collaborate closely…
VOYAGE scholarship program for young vascular surgeons
Th e Society for Vascular Surgery (SVS) Foundation, in partnership with the SVS Young Surgeons Section, has launched the VOYAGE Scholarship Program. This initiative will provide $1,000 scholarships to assist early-career vascular surgeons during their formative years in the profession. The…
VAM 2025 abstract submission period opens
Vascular surgeon-scientists may submit their research for presentation at the 2025 Vascular Annual Meeting (VAM) in June through Wednesday, Jan. 8, 2025. The submission period opened Nov. 6. VAM research—both clinical and translational—is considered for presentation in several different forums…